default author photo

Ebrahim Variava

University of the Witwatersrand - Department of Internal Medicine

Johannesburg

South Africa

SCHOLARLY PAPERS

2

DOWNLOADS

185

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

An All-Oral 6-Month Regimen for Multi-Drug Resistant/Rifampicin-Resistant Tuberculosis: A Multi-Centre, Phase 3, Open Label, Randomised Controlled Trial (NeXT Study)

Number of pages: 47 Posted: 28 Jul 2021
University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, South African Medical Research Council - Biostatistics Unit, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Sefako Makgatho Health Sciences University - Department of Intensive Care, University of the Witwatersrand - Department of Internal Medicine, Walter Sisulu University - Department of Medicine, Walter Sisulu University - Head of Pulmonology, University of Kwazulu-Natal, Don Makenzie Hospital, Harry Comay Hospital, Harry Comay Hospital, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - University of Cape Town Lung Institute, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, Brooklyn Chest Hospital, Stellenbosch University - Division of Molecular Biology and Human Genetics, National Department of Health - Drug Resistant TB Directorate, University of Cape Town (UCT) - Division of Clinical Pharmacology, Stellenbosch University - Division of Molecular Biology and Human Genetics and University of the Witwatersrand - Perinatal HIV Research Unit
Downloads 132 (551,165)
Citation 3

Abstract:

Loading...

2.

Weight Gain, Body Composition and Metabolic Parameters on Dolutegravir-Based Antiretroviral Therapy Versus Standard of Care in Children and Adolescents: A Secondary Analysis of the ODYSSEY Trial

Number of pages: 30 Posted: 11 Sep 2025
University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University of the Witwatersrand - Perinatal HIV Research Unit, Department of Paediatrics, University of Zimbabwe, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Mbarara, Joint Clinical Research Centre, Mahasarakam Hospital, Makerere University - Johns Hopkins University Research Collaboration, University of the Witwatersrand - Department of Internal Medicine, University of KwaZulu-Natal, Stellenbosch University, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, University of Zimbabwe, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Chris Hani Baragwanath Academic Hospital, Goethe University, University Hospitals Birmingham NHS Foundation Trust, Research on AIDS and Viral Hepatitis (ANRS), University College London - Infection, Immunity and Inflammation Research & Teaching Department, Chiang Mai University, Makerere University - Johns Hopkins University Research Collaboration, Joint Clinical Research Centre, London School of Hygiene & Tropical Medicine - Department of Clinical Research, University of Padua - Department of Women’s and Children’s Health, University of Padua, University College London - MRC Clinical Trials Unit and University College London - MRC Clinical Trials Unit
Downloads 53 (1,041,696)

Abstract:

Loading...

HIV, children, adolescents, dolutegravir, weight-gain, body fat percentage, lipid profile, glycaemia